{"name":"Jennifer Gassman, PhD","slug":"jennifer-gassman-phd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Higher Dose Sodium Bicarbonate","genericName":"Higher Dose Sodium Bicarbonate","slug":"higher-dose-sodium-bicarbonate","indication":"Acute kidney injury prevention or treatment (Phase 3 investigational)","status":"phase_3"}]},{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Lower Dose Sodium Bicarbonate","genericName":"Lower Dose Sodium Bicarbonate","slug":"lower-dose-sodium-bicarbonate","indication":"Chronic kidney disease with metabolic acidosis","status":"phase_3"}]}],"pipeline":[{"name":"Higher Dose Sodium Bicarbonate","genericName":"Higher Dose Sodium Bicarbonate","slug":"higher-dose-sodium-bicarbonate","phase":"phase_3","mechanism":"Higher dose sodium bicarbonate raises blood and urine pH to create an alkaline environment that may reduce kidney injury and improve renal function.","indications":["Acute kidney injury prevention or treatment (Phase 3 investigational)","Chronic kidney disease progression (Phase 3 investigational)"],"catalyst":""},{"name":"Lower Dose Sodium Bicarbonate","genericName":"Lower Dose Sodium Bicarbonate","slug":"lower-dose-sodium-bicarbonate","phase":"phase_3","mechanism":"Lower dose sodium bicarbonate raises blood and urine pH to reduce acid load and slow progression of chronic kidney disease.","indications":["Chronic kidney disease with metabolic acidosis"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":2,"phaseCounts":{"phase_3":2},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}